| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10549-016-4027-1 |
| P8608 | Fatcat ID | release_qfpqxyymjrcsjb6iohifg4sjhy |
| P698 | PubMed publication ID | 27796714 |
| P50 | author | Young Kyung Bae | Q80059987 |
| Jung-Ae Kim | Q87859352 | ||
| P2093 | author name string | Jaya Gautam | |
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance | Q24645668 | ||
| Role for cysteine protease cathepsins in heart disease: focus on biology and mechanisms with clinical implication | Q26864203 | ||
| Hsp90 isoforms: functions, expression and clinical importance | Q28255212 | ||
| Expression of cathepsins B and S in the progression of prostate carcinoma | Q32160033 | ||
| Degradation of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of breast cancer cells | Q33637919 | ||
| Distinct roles for cysteine cathepsin genes in multistage tumorigenesis | Q34471105 | ||
| Hsp90 inhibitors as novel cancer chemotherapeutic agents | Q34583912 | ||
| Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S | Q34599128 | ||
| Cysteine cathepsins and the cutting edge of cancer invasion | Q34605340 | ||
| High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer | Q35546764 | ||
| The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study | Q35623073 | ||
| Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. | Q37369658 | ||
| Deciphering the role of PI3K/Akt/mTOR pathway in breast cancer biology and pathogenesis | Q37813282 | ||
| Blockade of CD47-mediated cathepsin S/protease-activated receptor 2 signaling provides a therapeutic target for hepatocellular carcinoma. | Q39024382 | ||
| Silencing cathepsin S gene expression inhibits growth, invasion and angiogenesis of human hepatocellular carcinoma in vitro. | Q39314730 | ||
| miR-520c and miR-373 upregulate MMP9 expression by targeting mTOR and SIRT1, and activate the Ras/Raf/MEK/Erk signaling pathway and NF-κB factor in human fibrosarcoma cells | Q39427500 | ||
| PI3K/Akt-dependent transcriptional regulation and activation of BMP-2-Smad signaling by NF-kappaB in metastatic prostate cancer cells | Q39926569 | ||
| High HSP90 expression is associated with decreased survival in breast cancer | Q40149432 | ||
| Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines | Q40168416 | ||
| Antibody-mediated inhibition of cathepsin S blocks colorectal tumor invasion and angiogenesis | Q43269533 | ||
| Fibronectin expression in carcinoma cells correlates with tumor aggressiveness and poor clinical outcome in patients with invasive breast cancer. | Q43728820 | ||
| Association between serum cathepsin S and mortality in older adults | Q44578257 | ||
| Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors. | Q46859366 | ||
| Binding of chondroitin 4-sulfate to cathepsin S regulates its enzymatic activity | Q47724503 | ||
| Cathepsin S expression: An independent prognostic factor in glioblastoma tumours--A pilot study | Q48610874 | ||
| Molecular fingerprinting and autocrine growth regulation of endothelial cells in a murine model of hepatocellular carcinoma. | Q53350643 | ||
| Secretory leucocyte protease inhibitor inhibits interferon-gamma-induced cathepsin S expression. | Q53526931 | ||
| Androgen receptor expression predicts decreased survival in early stage triple-negative breast cancer. | Q54328011 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 29-40 | |
| P577 | publication date | 2016-10-27 | |
| P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
| P1476 | title | Up-regulation of cathepsin S expression by HSP90 and 5-HT7 receptor-dependent serotonin signaling correlates with triple negativity of human breast cancer | |
| P478 | volume | 161 |
| Q90636437 | 5-HT7 Receptor Contributes to Proliferation, Migration and Invasion in NSCLC Cells |
| Q92187139 | A Novel Role for Cathepsin S as a Potential Biomarker in Triple Negative Breast Cancer |
| Q58763841 | Down-regulation of cathepsin S and matrix metalloproteinase-9 via Src, a non-receptor tyrosine kinase, suppresses triple-negative breast cancer growth and metastasis |
| Q99406536 | Heat shock protein 90α in thymic epithelial tumors and non-thymomatous myasthenia gravis |
| Q88636947 | Integrated bioinformatics analysis reveals that the expression of cathepsin S is associated with lymph node metastasis and poor prognosis in papillary thyroid cancer |
Search more.